AJMC February 22, 2023
Angela Storseth-Cooper, Lalan Wilfong, MD

When treating patients with complex health care needs, particularly those living with cancer, time is of the essence. So, too, is access to personalized medicine.

Clinical decisions regarding the specific treatments, therapies, and medications used in the course of oncological care should be patient centered, physician driven, and evidence based. That is why community oncology practices, in partnership with The US Oncology Network and the National Comprehensive Cancer Network, developed a set of evidence-based, physician-led Value Pathways to improve the quality of cancer care and significantly reduce costs.1

Unfortunately, not everyone shares these values. Cost-containing measures and profit-driven decisions made by health insurers, as well as their affiliated pharmacy benefit managers (PBMs) and specialty pharmacies, often dictate the care patients...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Estonian Biobank to Sequence 10,000 Genomes as Part of Precision Medicine Project
Precision Immune Start-Up Mirador Launches with $400M+
The future of companion diagnostic (CDx) development: Why commercialization is key
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs

Share This Article